Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10134)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2017 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jain A, Lipson EJ, Sharfman WH, Brant SR, Lazarev MG. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis. World J Gastroenterol 2017; 23(11): 2023-2028 [PMID: 28373768 DOI: 10.3748/wjg.v23.i11.2023] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i11/2023.htm |
| Number | Citing Articles |
| 1 |
Michael S. Hughes, Hui Zheng, Leyre Zubiri, Gabriel E. Molina, Steven T. Chen, Meghan J. Mooradian, Ian M. Allen, Kerry L. Reynolds, Michael Dougan. Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control. Cancer Medicine 2019; 8(11): 4986 doi: 10.1002/cam4.2397
|
| 2 |
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseases. World Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
|
| 3 |
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli. Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for ImmunoTherapy of Cancer 2024; 12(1): e007409 doi: 10.1136/jitc-2023-007409
|
| 4 |
Sing-Ting Wang, Ming-Yu Lien. Severe Colitis Induced by Pembrolizumab in a Patient with Advanced Hypopharyngeal Squamous Cell Carcinoma. Journal of Cancer Research and Practice 2021; 8(3): 113 doi: 10.4103/JCRP.JCRP_5_21
|
| 5 |
Matthew R. Pugh, Gareth D. Leopold, Meleri Morgan, Adam D. Christian, Rhys Hewett, Dharmaraj Durai, John Wagstaff, Dean Harris, Stefan D. Dojcinov. Epstein-Barr Virus-Positive Mucocutaneous Ulcers Complicate Colitis Caused by Immune Checkpoint Regulator Therapy and Associate With Colon Perforation. Clinical Gastroenterology and Hepatology 2020; 18(8): 1785 doi: 10.1016/j.cgh.2019.09.031
|
| 6 |
Manreet Randhawa, Gregory Gaughran, Christine Archer, Paul Pavli, Adrienne Morey, Sayed Ali, Desmond Yip. Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report. World Journal of Clinical Oncology 2019; 10(10): 349 doi: 10.5306/wjco.v10.i10.349
|
| 7 |
Aniruddh Som, Rohan Mandaliya, Dana Alsaadi, Maham Farshidpour, Aline Charabaty, Nidhi Malhotra, Mark C Mattar. Immune checkpoint inhibitor-induced colitis: A comprehensive review. World Journal of Clinical Cases 2019; 7(4): 405-418 doi: 10.12998/wjcc.v7.i4.405
|
| 8 |
I. Puzanov, A. Diab, K. Abdallah, C. O. Bingham, C. Brogdon, R. Dadu, L. Hamad, S. Kim, M. E. Lacouture, N. R. LeBoeuf, D. Lenihan, C. Onofrei, V. Shannon, R. Sharma, A. W. Silk, D. Skondra, M. E. Suarez-Almazor, Y. Wang, K. Wiley, H. L. Kaufman, M. S. Ernstoff. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. Journal for ImmunoTherapy of Cancer 2017; 5(1) doi: 10.1186/s40425-017-0300-z
|
| 9 |
Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Melissa Lumish, Tianqi Chen, Anita Giobbie-Hurder, Douglas B. Johnson, Ryan J. Sullivan, Michael Dougan. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis. Journal for ImmunoTherapy of Cancer 2020; 8(1): e000451 doi: 10.1136/jitc-2019-000451
|
| 10 |
Paola Triggianese, Lucia Novelli, Maria Rosaria Galdiero, Maria Sole Chimenti, Paola Conigliaro, Roberto Perricone, Carlo Perricone, Roberto Gerli. Immune checkpoint inhibitors-induced autoimmunity: The impact of gender. Autoimmunity Reviews 2020; 19(8): 102590 doi: 10.1016/j.autrev.2020.102590
|
| 11 |
Mar Riveiro-Barciela, Sabela carballal, Álvaro Díaz-González, Miriam Mañosa, Javier Gallgo-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.10250/2024
|
| 12 |
Caroline Prieux-Klotz, Marie Dior, Diane Damotte, Johann Dreanic, Bertrand Brieau, Catherine Brezault, Vered Abitbol, Stanislas Chaussade, Romain Coriat. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management. Targeted Oncology 2017; 12(3): 301 doi: 10.1007/s11523-017-0495-4
|
| 13 |
Sai‐Ching J. Yeung, Carmen P. Escalante. Holland‐Frei Cancer Medicine. 2022; : 1 doi: 10.1002/9781119000822.hfcm141.pub2
|
| 14 |
Shunichi Yanai, Yosuke Toya, Tamotsu Sugai, Takayuki Matsumoto. Gastrointestinal Adverse Events Induced by Immune-Checkpoint Inhibitors. Digestion 2021; 102(6): 965 doi: 10.1159/000518543
|
| 15 |
Shunichi Yanai, Tamotsu Sugai, Takayuki Matsumoto. Colitis Induced by Immune-checkpoint Inhibitors. Nippon Daicho Komonbyo Gakkai Zasshi 2021; 74(10): 599 doi: 10.3862/jcoloproctology.74.599
|
| 16 |
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología (English Edition) 2024; 47(4): 401 doi: 10.1016/j.gastre.2023.10.003
|
| 17 |
James Isaacs, Afreen Idris Shariff, Jeffrey Crawford, Michel Khouri, Meenal Kheterpal, Sarah Sammons, Michelle Nelson Ferreira, April Wall, Jane E. Onken, Lindsay King, Suma Shah, David I. Ortiz-Melo, Sophia C. Weinmann. Side Effects of Cancer Therapy. 2024; : 1 doi: 10.1007/978-3-030-93702-7_12-2
|
| 18 |
Mark A. Samaan, Polychronis Pavlidis, Sophie Papa, Nick Powell, Peter M. Irving. Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management. Nature Reviews Gastroenterology & Hepatology 2018; 15(4): 222 doi: 10.1038/nrgastro.2018.14
|
| 19 |
Maria-Carlota Londoño, Maria Reig. Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors. Cancers 2020; 12(11): 3446 doi: 10.3390/cancers12113446
|
| 20 |
Yinghong Wang, Hamzah Abu-Sbeih, Emily Mao, Noman Ali, Wei Qiao, Van Anh Trinh, Chrystia Zobniw, Daniel Hartman Johnson, Rashmi Samdani, Phillip Lum, Gladis Shuttlesworth, Boris Blechacz, Robert Bresalier, Ethan Miller, Selvi Thirumurthi, David Richards, Gottumukkala Raju, John Stroehlein, Adi Diab. Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflammatory Bowel Diseases 2018; 24(8): 1695 doi: 10.1093/ibd/izy104
|
| 21 |
O. Gómez-Escudero. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo. Revista de Gastroenterología de México 2024; 89(1): 89 doi: 10.1016/j.rgmx.2023.11.001
|
| 22 |
Yohei Yamauchi, Makoto Arai, Naoki Akizue, Yuki Ohta, Kenichiro Okimoto, Tomoaki Matsumura, Meng Meng Fan, Chiaki Imai, Akinobu Tawada, Jun Kato, Naoya Kato, Yuichi Takiguchi. Colonoscopic evaluation of diarrhea/colitis occurring as an immune-related adverse event. Japanese Journal of Clinical Oncology 2021; 51(3): 363 doi: 10.1093/jjco/hyaa203
|
| 23 |
Susanne Krege. Uroonkologie. Springer Reference Medizin 2019; : 1 doi: 10.1007/978-3-662-54652-9_26-1
|
| 24 |
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Igor Puzanov, Cristina A. Reichner, Bianca D. Santomasso, Carole Seigel, Alexander Spira, Maria E. Suarez-Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 2018; 36(17): 1714 doi: 10.1200/JCO.2017.77.6385
|
| 25 |
Manreet Randhawa, Gregory Gaughran, Christine Archer, Paul Pavli, Adrienne Morey, Sayed Ali, Desmond Yip. Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report. World Journal of Clinical Oncology 2019; 10(10): 350-357 doi: 10.5306/wjco.v10.i10.350
|
| 26 |
Bryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marianne J. Davies, Marc S. Ernstoff, Leslie Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S. Mammen, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Cristina A. Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A. Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S. Weber, Pauline Funchain, Kathryn Bollin. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Journal of Clinical Oncology 2021; 39(36): 4073 doi: 10.1200/JCO.21.01440
|
| 27 |
Laura Spiers, Nicholas Coupe, Miranda Payne. Toxicities associated with checkpoint inhibitors—an overview. Rheumatology 2019; 58(Supplement_7): vii7 doi: 10.1093/rheumatology/kez418
|
| 28 |
Shipra Gandhi, Aman Gupta, Marc S. Ernstoff. Handbook of Cancer Treatment-Related Symptons and Toxicities. 2020; : 201 doi: 10.1016/B978-0-323-67241-2.00019-7
|
| 29 |
Dorte Lisbet Nielsen, Carsten Bogh Juhl, Inna Markovna Chen, Lauge Kellermann, Ole Haagen Nielsen. Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis. Cancer Treatment Reviews 2022; 109: 102440 doi: 10.1016/j.ctrv.2022.102440
|
| 30 |
Merve Özkan. Managing Side Effects of Breast Cancer Treatment. 2024; : 67 doi: 10.1007/978-3-031-75480-7_6
|
| 31 |
Zeynep B. Zengin, Nicholas J. Salgia, Alexander Chehrazi-Raffle, Luis Meza, Jasnoor Malhotra, Sumanta K. Pal. Immune Related Adverse Events. The Cancer Journal 2020; 26(5): 432 doi: 10.1097/PPO.0000000000000473
|
| 32 |
Mohsin Shah, Eva Rajha, Courtney DiNardo, Erin Muckey, William G. Wierda, Sai-Ching J. Yeung. Adverse Events of Novel Therapies for Hematologic Malignancies: What Emergency Physicians Should Know. Annals of Emergency Medicine 2020; 75(2): 264 doi: 10.1016/j.annemergmed.2019.07.015
|
| 33 |
Emilie Soularue, Patricia Lepage, Jean Frederic Colombel, Clelia Coutzac, David Faleck, Lysiane Marthey, Michael Collins, Nathalie Chaput, Caroline Robert, Franck Carbonnel. Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut 2018; 67(11): 2056 doi: 10.1136/gutjnl-2018-316948
|
| 34 |
Vincent Ting Fung Cheung, Oliver Brain. Immunotherapy induced enterocolitis and gastritis – What to do and when?. Best Practice & Research Clinical Gastroenterology 2020; : 101703 doi: 10.1016/j.bpg.2020.101703
|
| 35 |
Imen Tlili, Hela Chikh Rouhou, Riadh Ilahy, Emna Jedidi, Rym Bouhlel, Leila Romdhane, Samir Ghannem, Marcello Salvatore Lenucci, Mohammed Wasim Siddiqui, Thouraya R’him, Chafik Hdider. Antioxidants in Vegetables and Nuts - Properties and Health Benefits. 2020; : 105 doi: 10.1007/978-981-15-7470-2_5
|
| 36 |
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología 2024; 47(4): 401 doi: 10.1016/j.gastrohep.2023.10.009
|
| 37 |
John A. Thompson, Bryan J. Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew Frigault, Brianna Hoffner, Christopher J. Hoimes, Mario Lacouture, Frederick Locke, Matthew Lunning, Nisha A. Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan Oluwole, Sandip P. Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone. Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2019; 17(3): 255 doi: 10.6004/jnccn.2019.0013
|
| 38 |
Hajir Ibraheim, Samantha Baillie, Mark A. Samaan, Hamzah Abu‐Sbeih, Yinghong Wang, Nicholas J. Talley, Michael P. Jones, Nick Powell. Systematic review with meta‐analysis: effectiveness of anti‐inflammatory therapy in immune checkpoint inhibitor‐induced enterocolitis. Alimentary Pharmacology & Therapeutics 2020; 52(9): 1432 doi: 10.1111/apt.15998
|
| 39 |
Wendy Zhou, Joseph Frye, Camille Soroudi, George Triadafilopoulos, Rani Berry. From ICI to ICU: Ipilimumab and Nivolumab-Induced Immune Checkpoint Inhibitor Colitis. Digestive Diseases and Sciences 2022; 67(3): 800 doi: 10.1007/s10620-021-07100-4
|
| 40 |
Sae Ohwada, Keisuke Ishigami, Yoshihiro Yokoyama, Tomoe Kazama, Yoshiharu Masaki, Mamoru Takahashi, Shinji Yoshii, Hiro-o Yamano, Hirofumi Chiba, Hiroshi Nakase. Immune-related colitis and pancreatitis treated with infliximab. Clinical Journal of Gastroenterology 2023; 16(1): 73 doi: 10.1007/s12328-022-01731-4
|
| 41 |
Valérie Desmedt, Aranzazu Jauregui-Amezaga, Liselotte Fierens, Sandrine Aspeslagh, Jeroen Dekervel, Els Wauters, Marc Peeters, Joao Sabino, Lara Crapé, Michael Somers, Anne Hoorens, Joris Dutré, Triana Lobatón. Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus. European Journal of Cancer 2023; 187: 36 doi: 10.1016/j.ejca.2023.03.025
|
| 42 |
|
| 43 |
Jacob Lambdin, Marie Borum. Toxic Injury to the Gastointestinal Tract After Ipilimumab Therapy. Journal of Osteopathic Medicine 2018; 118(8): 506 doi: 10.7556/jaoa.2018.118
|
| 44 |
Kelley Ratermann, Jessica Cox, Lydia Benitez, Frank Davis. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2018; 40: 477 doi: 10.1016/bs.seda.2018.07.010
|
| 45 |
Darren CR. Fernandes, H. Jervoise N Andreyev. Chronic diarrhoea in an oncology patient – Clinical assessment and decision making. Best Practice & Research Clinical Gastroenterology 2020; : 101708 doi: 10.1016/j.bpg.2020.101708
|
| 46 |
Beatriz Wills, Julie R. Brahmer, Jarushka Naidoo. Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer. Current Treatment Options in Oncology 2018; 19(9) doi: 10.1007/s11864-018-0562-9
|
| 47 |
Nick Powell, Hajir Ibraheim, Tim Raine, Richard A Speight, Sophie Papa, Oliver Brain, Michael Green, Mark A Samaan, Lavinia Spain, Nadia Yousaf, Nikki Hunter, Lucy Eldridge, Polychronis Pavlidis, Peter Irving, Bu'Hussain Hayee, Samra Turajlic, James Larkin, James O Lindsay, Martin Gore. British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. The Lancet Gastroenterology & Hepatology 2020; 5(7): 679 doi: 10.1016/S2468-1253(20)30014-5
|
| 48 |
Spyros I. Siakavellas, Giorgos Bamias. Checkpoint inhibitor colitis. Current Opinion in Gastroenterology 2018; 34(6): 377 doi: 10.1097/MOG.0000000000000482
|
| 49 |
Sara El Ouali, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020; : 451 doi: 10.1016/B978-0-12-814811-2.00029-3
|
| 50 |
O. Gómez Escudero. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist. Revista de Gastroenterología de México (English Edition) 2024; 89(1): 89 doi: 10.1016/j.rgmxen.2023.11.001
|
| 51 |
Ashley N. Tran, Melinda Wang, Melanie Hundt, Rishika Chugh, Jonathan Ohm, Alyssa Grimshaw, Maria Ciarleglio, Kenneth W. Hung, Deborah D. Proctor, Christina C. Price, Loren Laine, Badr Al-Bawardy. Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies. Journal of Immunotherapy 2021; 44(8): 325 doi: 10.1097/CJI.0000000000000383
|
| 52 |
James Isaacs, Afreen Shariff, Jeffrey Crawford. Side Effects of Cancer Therapy. 2024; : 1 doi: 10.1007/978-3-030-93702-7_12-1
|
| 53 |
Michael Collins, Emilie Soularue, Lysiane Marthey, Franck Carbonnel. Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review. Clinical Gastroenterology and Hepatology 2020; 18(6): 1393 doi: 10.1016/j.cgh.2020.01.033
|
| 54 |
Vincent Ting Fung Cheung, Tarun Gupta, Anna Olsson-Brown, Sreedhar Subramanian, Sarah Christina Sasson, Jonathan Heseltine, Eve Fryer, Elena Collantes, Joseph J. Sacco, Munir Pirmohamed, Alison Simmons, Paul Klenerman, Mark Tuthill, Andrew S. Protheroe, Meenali Chitnis, Benjamin Peter Fairfax, Miranda Jane Payne, Mark Ross Middleton, Oliver Brain. Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?. British Journal of Cancer 2020; 123(2): 207 doi: 10.1038/s41416-020-0882-y
|
| 55 |
Emanuelle Bellaguarda, Stephen Hanauer. Checkpoint Inhibitor–Induced Colitis. American Journal of Gastroenterology 2020; 115(2): 202 doi: 10.14309/ajg.0000000000000497
|
| 56 |
Eva Rajha, Sai-Ching Jim Yeung. Oncologic Emergency Medicine. 2021; : 711 doi: 10.1007/978-3-030-67123-5_53
|
| 57 |
Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu, Hiroshi Nakase. Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis. Biomedicines 2022; 10(6): 1334 doi: 10.3390/biomedicines10061334
|
| 58 |
Julian Burla, Sena Bluemel, Luc Biedermann, Marjam J. Barysch, Reinhard Dummer, Mitchell P. Levesque, Christoph Gubler, Bernhard Morell, Gerhard Rogler, Michael Scharl. Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease Course. Inflammatory Intestinal Diseases 2020; 5(3): 109 doi: 10.1159/000507579
|
| 59 |
Khang Duy Ricky Le, Kay Tai Choy, Sara Roth, Alexander G. Heriot, Joseph C. H. Kong. Immune mediated colitis: a surgical perspective. ANZ Journal of Surgery 2023; 93(6): 1495 doi: 10.1111/ans.18485
|
| 60 |
Paul T. Kröner, Kabir Mody, Francis A. Farraye. Immune checkpoint inhibitor–related luminal GI adverse events. Gastrointestinal Endoscopy 2019; 90(6): 881 doi: 10.1016/j.gie.2019.09.009
|
| 61 |
Liansha Tang, Jialing Wang, Nan Lin, Yuwen Zhou, Wenbo He, Jiyan Liu, Xuelei Ma. Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.800879
|
| 62 |
Yasuo Hamamoto, Natalya Shin, Tomohiro Hoshino, Takanori Kanai. Management of Challenging Immune-Related Gastrointestinal Adverse Events Associated with Immune Checkpoint Inhibitors. Future Oncology 2018; 14(30): 3187 doi: 10.2217/fon-2018-0509
|
| 63 |
Sai‐Ching Jim Yeung, Aiham Qdaisat, Patrick Chaftari, Demis Lipe, Jeffrey Merlin, Eva Rajha, Adriana Wechsler, Marcelo Sandoval, Jayne Viets, Aisha Al‐Breiki, Mohsin Shah, Ramesh Pandey, Mona Kamal, Osama Khattab, Katy Toale, Monica Wattana, Ahmed Elsayem, Susan Gaeta, Patricia Brock, Cielito Reyes‐Gibby, Kumar Alagappan. Diagnosis and management of immune‐related adverse effects of immune checkpoint therapy in the emergency department. JACEP Open 2020; 1(6): 1637 doi: 10.1002/emp2.12209
|
| 64 |
Samuel C.L. Smith, Davide Zardo, Rosanna Cannatelli, Neil Stevens, Marietta Iacucci. Endoscopic findings of checkpoint inhibitor–induced ileitis with use of the latest advanced endoscopic optical diagnosis: near-focus narrow-band imaging. VideoGIE 2019; 4(3): 133 doi: 10.1016/j.vgie.2018.11.005
|
| 65 |
B. L. Adler, M. K. Pezhouh, A. Kim, L. Luan, Q. Zhu, F. Gani, M. Yarchoan, J. Chen, L. Voltaggio, A. Parian, M. Lazarev, G. Y. Lauwers, T. M. Pawlik, E. A. Montgomery, E. Jaffee, D. T. Le, J. M. Taube, R. A. Anders. Histopathological and immunophenotypic features of ipilimumab‐associated colitis compared to ulcerative colitis. Journal of Internal Medicine 2018; 283(6): 568 doi: 10.1111/joim.12744
|
| 66 |
Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases 2024; 30(6): 1018 doi: 10.1093/ibd/izad229
|
| 67 |
Takayuki Ando, Miho Sakumura, Hiroshi Mihara, Haruka Fujinami, Ichiro Yasuda. A Review of Potential Role of Capsule Endoscopy in the Work-Up for Chemotherapy-Induced Diarrhea. Healthcare 2022; 10(2): 218 doi: 10.3390/healthcare10020218
|
| 68 |
Min Ding, Xianxian Zhang, Jing Wang, Fangbo Gao, Xiaojie Zheng, Jinqiu Yuan, Xingshun Qi. Treatment and outcomes of immune checkpoint inhibitors-associated colitis/diarrhea: A systematic review and meta-analysis. Digestive and Liver Disease 2023; 55(12): 1621 doi: 10.1016/j.dld.2023.02.016
|